Enterprise Value

89.94M

Cash

70.18M

Avg Qtr Burn

N/A

Short % of Float

14.73%

Insider Ownership

9.41%

Institutional Own.

45.74%

Qtr Updated

06/30/23


Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & IndicationStage & EventCatalyst Date

Approved

Quarterly sales

Approved

Quarterly sales

Approved

Quarterly sales

Approved

Quarterly sales

INDOCIN Oral Suspension Details
RA (Rheumatoid arthritis)

Approved

Quarterly sales

Approved

Quarterly sales